ZA201602703B - A molecular marker of plasmodium falciparum artemisinin resistance - Google Patents

A molecular marker of plasmodium falciparum artemisinin resistance

Info

Publication number
ZA201602703B
ZA201602703B ZA2016/02703A ZA201602703A ZA201602703B ZA 201602703 B ZA201602703 B ZA 201602703B ZA 2016/02703 A ZA2016/02703 A ZA 2016/02703A ZA 201602703 A ZA201602703 A ZA 201602703A ZA 201602703 B ZA201602703 B ZA 201602703B
Authority
ZA
South Africa
Prior art keywords
molecular marker
plasmodium falciparum
artemisinin resistance
artemisinin
resistance
Prior art date
Application number
ZA2016/02703A
Other languages
English (en)
Inventor
Frederic Ariey
Odile Puijalon
Didier Menard
Francoise Benoit-Vical
Johann Beghain
Benoit Witkowski
Jean-Christophe Barale
Christiane Bouchier
Nimol Khim
Original Assignee
Pasteur Institut
Inst Pasteur Du Cambodge
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Pasteur Du Cambodge, Centre Nat Rech Scient filed Critical Pasteur Institut
Publication of ZA201602703B publication Critical patent/ZA201602703B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/445Plasmodium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA2016/02703A 2013-11-15 2016-04-19 A molecular marker of plasmodium falciparum artemisinin resistance ZA201602703B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361904651P 2013-11-15 2013-11-15
US201462062439P 2014-10-10 2014-10-10
PCT/IB2014/002910 WO2015071759A1 (en) 2013-11-15 2014-11-14 A molecular marker of plasmodium falciparum artemisinin resistance

Publications (1)

Publication Number Publication Date
ZA201602703B true ZA201602703B (en) 2019-12-18

Family

ID=52440720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2016/02703A ZA201602703B (en) 2013-11-15 2016-04-19 A molecular marker of plasmodium falciparum artemisinin resistance

Country Status (10)

Country Link
US (2) US10900093B2 (https=)
EP (1) EP3068903B1 (https=)
JP (2) JP6667445B2 (https=)
KR (1) KR102283408B1 (https=)
CN (1) CN105940115B (https=)
AU (1) AU2014349828B2 (https=)
BR (1) BR112016011046A2 (https=)
ES (1) ES2720728T3 (https=)
WO (1) WO2015071759A1 (https=)
ZA (1) ZA201602703B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3497237B1 (en) 2016-08-10 2022-05-04 Institut Pasteur Methods and reagents for detecting piperaquine-resistant plasmodium falciparum malaria
CN109504791A (zh) * 2018-12-29 2019-03-22 潮州市人民医院 用于检测疟原虫青蒿素耐药性相关k13基因突变的试剂盒
CN109897901A (zh) * 2019-02-27 2019-06-18 四川国际旅行卫生保健中心 检测恶性疟原虫k13基因突变位点的特异性引物组及其应用
CN109797207A (zh) * 2019-02-27 2019-05-24 四川国际旅行卫生保健中心 一种检测恶性疟原虫k13基因四个抗性突变位点的方法
CN112592395A (zh) * 2020-12-11 2021-04-02 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) 一种恶性疟原虫RIFIN重组蛋白PfRIFIN-54的构建、制备及用途

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4411993A (en) 1981-04-29 1983-10-25 Steven Gillis Hybridoma antibody which inhibits interleukin 2 activity
USRE32011E (en) 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4543439A (en) 1982-12-13 1985-09-24 Massachusetts Institute Of Technology Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4902614A (en) 1984-12-03 1990-02-20 Teijin Limited Monoclonal antibody to human protein C
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US5242794A (en) 1984-12-13 1993-09-07 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5333675C1 (en) 1986-02-25 2001-05-01 Perkin Elmer Corp Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
DE3689123T2 (de) 1985-11-01 1994-03-03 Xoma Corp Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
WO1989001050A1 (en) 1987-07-31 1989-02-09 The Board Of Trustees Of The Leland Stanford Junior University Selective amplification of target polynucleotide sequences
JP2650159B2 (ja) 1988-02-24 1997-09-03 アクゾ・ノベル・エヌ・ベー 核酸増幅方法
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US4988617A (en) 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
EP0436597B1 (en) 1988-09-02 1997-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
CA2005589C (en) 1988-12-16 2001-02-06 Akzo Nobel Nv Self-sustained, sequence replication system
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK0585287T3 (da) 1990-07-10 2000-04-17 Cambridge Antibody Tech Fremgangsmåde til fremstilling af specifikke bindingsparelementer
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
CA2095633C (en) 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
EP1820858B1 (en) 1991-03-01 2009-08-12 Dyax Corporation Chimeric protein comprising micro-protein having two or more disulfide bonds and embodiments thereof
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US5667988A (en) 1992-01-27 1997-09-16 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US6582938B1 (en) 2001-05-11 2003-06-24 Affymetrix, Inc. Amplification of nucleic acids
TWI521064B (zh) * 2007-05-28 2016-02-11 國立大學法人愛媛大學 用於偵測瘧原蟲之引子(二)
CN100535125C (zh) * 2007-06-28 2009-09-02 中国疾病预防控制中心寄生虫病预防控制所 用于扩增恶性疟原虫药物抗性相关基因的多重pcr引物及方法

Also Published As

Publication number Publication date
US10900093B2 (en) 2021-01-26
US11732312B2 (en) 2023-08-22
US20210198755A1 (en) 2021-07-01
JP2020043873A (ja) 2020-03-26
EP3068903A1 (en) 2016-09-21
WO2015071759A1 (en) 2015-05-21
CN105940115B (zh) 2021-07-06
US20160289774A1 (en) 2016-10-06
CA2928014A1 (en) 2015-05-21
ES2720728T3 (es) 2019-07-24
EP3068903B1 (en) 2019-02-13
JP2016537030A (ja) 2016-12-01
AU2014349828A1 (en) 2016-05-26
HK1225757A1 (en) 2017-09-15
JP6667445B2 (ja) 2020-03-18
KR102283408B1 (ko) 2021-07-29
WO2015071759A9 (en) 2016-06-23
BR112016011046A2 (pt) 2019-01-29
CN105940115A (zh) 2016-09-14
AU2014349828B2 (en) 2021-01-28
KR20160119753A (ko) 2016-10-14

Similar Documents

Publication Publication Date Title
IL245794A0 (en) Methods for detecting Plasmodium infection
EP2823767A4 (en) CATHETER
ZA201508642B (en) Malaria vaccine
SG11201401636YA (en) Multi-axis marker locator
GB2555067B (en) Marker deployment
EP2820569A4 (en) MEDIA MARK
GB2504847B (en) A tubular connection
ZA201500656B (en) Marker vaccine
HUE043069T2 (hu) Vezetékjelzõ
ZA201602703B (en) A molecular marker of plasmodium falciparum artemisinin resistance
PL3044775T3 (pl) Marker do kabli
GB2506845B (en) Modified tubular
GB201306627D0 (en) Marker
ZA201401783B (en) Soybean markers linked to phytophthora resistance
GB2510974B (en) Tubular structure having decorative layer
PL2885047T3 (pl) Wielowarstwowy przewód rurowy
GB201308321D0 (en) Top marker
FR2996774B1 (fr) Catheter a ballonnet gonflable
GB201311779D0 (en) Varying inductance
GB201314956D0 (en) Plaque marker for a garment hanger
GB201206334D0 (en) Mouse ball
ES1077225Y (es) Posavasos
GB201215134D0 (en) Fencing base
GB201208978D0 (en) Overcoming drug resistance
AU2013904616A0 (en) Methods of Detecting Plasmodium Infection